We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The case for vaccinating boys against human papillomavirus.
- Authors
Hull, Sarah C; Caplan, Arthur L
- Abstract
Vaccination policy in the case of human papillomavirus (HPV) has remained a constant source of controversy ever since Gardasil, Merck's vaccine against HPV, received US Food and Drug Administration approval in the summer of 2006. This controversy has centered on the risks and benefits of vaccinating girls and women in rich and poor nations alike. However, despite all of the attention created by this important policy question, relatively little has been focused on another key public health question: should boys be vaccinated against HPV as well? If herd immunity against the most carcinogenic strains of HPV could be more rapidly and efficiently achieved by vaccinating everyone at risk for being a carrier, it logically follows that vaccine policy should expand to include boys and men.
- Publication
Public health genomics, 2009, Vol 12, Issue 5-6, p362
- ISSN
1662-8063
- Publication type
Journal Article
- DOI
10.1159/000214926